Combination of cellular retinoic acid-binding protein 2 overexpression and all-trans retinoic acid synergistically inhibits oesophageal squamous cell carcinoma progression
The combination of CRABP2 overexpression and ATRA synergistically inhibits ESCC progression. All-trans retinoic acid may be a candidate therapy for ESCC, and CRABP2 overexpression could enhance the efficacy of ATRA treatment.
Authors
- Liyun Dai (ORCID: https://orcid.org/0000-0001-8664-9430)
- Mengyan Li (ORCID: https://orcid.org/0000-0002-8580-5283)
Institutions
- Xinjiang Medical University (CN)
- First Affiliated Hospital of Xinjiang Medical University (CN)
- Changji University (CN)
- Karamay Central Hospital (CN)
- Karamay Central Hospital of Xinjiang (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1007/s12672-025-04091-w
- Primary Topic
- Retinoids in leukemia and cellular processes
- Type
- article
- Field-Weighted Citation Impact
- 0.00